FDA Approved: SINUVA — Original Application (Intersect ENT, Inc.)

View source ↗

Summary

FDA approved SINUVA (mometasone furoate) from Intersect ENT as a drug-eluting implant to treat chronic rhinosinusitis with nasal polyps in adults after sinus su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• SINUVA (Mometasone furoate)

Snippet

ORIG AP for SINUVA (MOMETASONE FUROATE)